Oct 13, 2026 07:01AM
Oct 13, 2026 07:01AM
Oct 13, 2026 07:00AM
Oct 13, 2026 07:00AM
Oct 8, 2026 08:00AM
Oct 8, 2026 08:00AM
Oct 6, 2026 08:00AM Entera Bio adds former Gilead executive Laura Hamill to its board
Oct 6, 2026 08:00AM
Sep 25, 2026 03:15AM
Aug 27, 2026 09:44AM
Aug 27, 2026 08:00AM
Aug 18, 2026 08:00AM
Aug 18, 2026 08:00AM
Aug 7, 2026 04:05PM Entera Announces Second Quarter 2026 Financial Results and Business Updates
Aug 4, 2026 08:30AM
Aug 4, 2026 08:30AM
Jul 31, 2026 04:30PM
Jul 27, 2026 08:30AM
Jul 27, 2026 08:30AM
Jul 27, 2026 08:30AM
Jul 27, 2026 08:30AM Entera Bio Announces Pricing of Oversubscribed $275 Million Private Placement
Jun 24, 2026 06:46AM
Jun 22, 2026 08:30AM
Jun 22, 2026 08:30AM
Jun 16, 2026 08:33AM
Jun 16, 2026 08:33AM
Jun 15, 2026 08:45AM
Jun 15, 2026 08:45AM ENDO 2026 Oral Presentation Highlights Comparative Clinical Data for Entera’s Breakthrough Single Tablet EB613 (First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis)
Jun 15, 2026 08:45AM
May 28, 2026 08:50AM
May 28, 2026 08:50AM
May 8, 2026 04:05PM
Apr 14, 2026 08:45AM
Apr 2, 2026 08:46AM
Apr 2, 2026 08:45AM Entera Bio Announces Pricing of $10.0 Million Direct Investment by BVF Partners with Potential for up to $24.5 Million in Total Proceeds
Mar 27, 2026 04:05PM
Mar 4, 2026 08:30AM
Mar 4, 2026 08:30AM
Feb 11, 2026 09:03AM
Feb 11, 2026 09:00AM
Feb 9, 2026 08:50AM
Feb 9, 2026 08:50AM Entera Bio Appoints Former Pfizer Executive Geno J. Germano as Chairman of the Board Ahead of Key Milestones
Feb 4, 2026 08:02AM
Feb 4, 2026 08:00AM
Jan 21, 2026 08:31AM
Jan 21, 2026 08:30AM
Jan 21, 2026 08:30AM
Dec 24, 2025 06:44AM
Dec 23, 2025 08:30AM Entera Bio Congratulates the FNIH-ASBMR-SABRE Team on FDA’s Qualification of Total Hip BMD as Regulatory Endpoint: Huge Win for Osteoporosis Innovation
Dec 22, 2025 08:32AM

334,453 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All